WeVote
Log In

Bill

Bill

HB 1045

Prescription Drug Monitoring Program - Data Disclosure to Federal Law Enforcement - Limitation

2026 Regular Session Introduced by Bonnie Cullison

HB 1045 restricts Maryland's prescription drug monitoring database disclosures to federal law enforcement, tightening privacy protections around sensitive patient prescription records.

Hearing 2/26 at 1:00 p.m.
0
WeVote Research Nonpartisan
Bill Summary · HB 1045

Legislative bill overview

HB 1045 would limit the circumstances under which Maryland's Prescription Drug Monitoring Program (PDMP) can disclose patient data to federal law enforcement agencies. The bill constrains data sharing to specific authorized purposes rather than allowing broader disclosure practices currently in effect.

Why is this important

PDMPs track controlled substance prescriptions to prevent drug abuse and diversion, but they also contain sensitive personal health information. This bill addresses the tension between law enforcement access for investigations and patient privacy protections—a growing national concern as federal agencies increasingly request prescription records without clear statutory limitations.

Potential points of contention

  • Law enforcement opposition: Federal agencies and prosecutors may argue that data restrictions hamper investigations into drug trafficking, organized crime, or other federal offenses
  • Privacy vs. public safety balance: Disagreement over where the line should be drawn—whether current access is excessive or appropriately tailored to legitimate law enforcement needs
  • Implementation ambiguity: The bill's specific limitations are not detailed in available information, leaving questions about what constitutes "authorized purposes" and how restrictions will be enforced

Compiled from official sources — confirm details with the bill’s official record.

Sign in to ask a question.